Wednesday, 28 August 2019

Reuters Health Report: U.S. FDA grants orphan drug status to AstraZeneca's asthma drug Fasenra

Reuters.com Newsletter

U.S. FDA grants orphan drug status to AstraZeneca's asthma drug Fasenra

AstraZeneca said on Wednesday that the U.S. Food and Drug Administration granted orphan drug status for its drug to treat eosinophilic esophagitis and unveiled positive results from a late-stage trial on a triple-drug therapy targeting a severe lung disease.

Purdue Pharma in discussion on $10 billion-$12 billion offer to settle opioid lawsuits: sources

OxyContin maker Purdue Pharma LP and its owners, the Sackler family, are in discussion to settle more than 2,000 opioid lawsuits against the company for $10 billion to $12 billion, two people familiar with the matter said on Tuesday.

U.S. prices for multiple sclerosis drugs are on the rise

(Reuters Health) - Annual costs of disease modifying treatments for multiple sclerosis more than quadrupled from 2006 to 2016 as several new, costly medicines entered the market, a U.S. study suggests.

Alternate-day fasting associated with weight loss

(Reuters Health) - People who start fasting every other day may lose more weight than they would if they stuck to their usual eating habits, a small study suggests.

Childhood cancer survivors face variety of heart risks

(Reuters Health) - Childhood cancer survivors' risks for heart problems may be broader than what was previously recognized, researchers say.

J&J liable for $572 million in Oklahoma opioid epidemic trial; shares rise

An Oklahoma judge on Monday ordered Johnson & Johnson to pay $572.1 million to the state for its part in fueling an opioid epidemic by deceptively marketing addictive painkillers, a sum that was substantially less than investors had expected, driving up J&J's shares.

Pureed peanuts advised for infants to stave off allergy

(Reuters Health) - Feeding pureed peanut products regularly to babies before their first birthday could reduce their risk of developing peanut allergies later on, doctors advise.

FDA gives fast track status to AstraZeneca's diabetes drug Farxiga

AstraZeneca Plc said on Tuesday that the U.S. Food and Drug Administration has granted fast track status for the development of its diabetes drug Farxiga to prevent heart and kidney failure in patients with chronic kidney disease (CKD).

China's Sichuan province to remove restrictions on pig farming

China's southwestern province of Sichuan, the country's top pig-farming province, is removing some restrictions on hog production to stabilize supply after an epidemic of African swine fever reduced herds.

DEA to expand marijuana research after years of delay

The U.S. Drug Enforcement Administration said on Monday that it will move ahead with a long-delayed expansion of its marijuana research program, in a sign that the Trump administration's hostility to the drug may be waning as a growing number of states have legalized its use.

New Jersey officials speed up Newark lead pipe replacement with $120 million plan

New Jersey unveiled a $120 million plan on Monday to speed up the replacement of old lead pipes in Newark in response to mounting alarm about the toxic metal leaching into the drinking water in the state's largest city.

Related Videos

Elton John blasts press criticism of Harry and Meghan

Meet Kate Middleton's biggest fan

Introducing the all-new
Reuters News app

The new Reuters News app is here, redesigned from the ground up to fit your busy life.

Get it now on iOS